Xue Dong

1.3k total citations
47 papers, 994 citations indexed

About

Xue Dong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Xue Dong has authored 47 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Immunology. Recurrent topics in Xue Dong's work include Cancer-related molecular mechanisms research (5 papers), Sirtuins and Resveratrol in Medicine (5 papers) and Immune Response and Inflammation (5 papers). Xue Dong is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Sirtuins and Resveratrol in Medicine (5 papers) and Immune Response and Inflammation (5 papers). Xue Dong collaborates with scholars based in China, Japan and United States. Xue Dong's co-authors include Liming Yu, Huishan Wang, Xiaodong Xue, Yang Yang, Jian Zhang, Zhi Li, Yinli Xu, Haibo Wu, Zhishang Wang and Zhonglu Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Xue Dong

43 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue Dong China 18 509 149 140 122 119 47 994
Yanli Cheng China 16 517 1.0× 135 0.9× 87 0.6× 159 1.3× 69 0.6× 47 1.1k
Yinli Xu China 15 488 1.0× 206 1.4× 109 0.8× 109 0.9× 57 0.5× 34 953
Manling Liu China 17 388 0.8× 102 0.7× 80 0.6× 110 0.9× 216 1.8× 30 823
Silvia Palmerio Italy 9 505 1.0× 221 1.5× 128 0.9× 257 2.1× 56 0.5× 18 1.1k
Xiaopei Cui China 15 595 1.2× 73 0.5× 195 1.4× 108 0.9× 69 0.6× 43 1.2k
Lele Ji China 18 784 1.5× 181 1.2× 215 1.5× 185 1.5× 58 0.5× 31 1.3k
Xiangning Cui China 18 537 1.1× 158 1.1× 145 1.0× 88 0.7× 171 1.4× 34 1.2k
Manyu Luo China 19 508 1.0× 76 0.5× 142 1.0× 74 0.6× 83 0.7× 43 1.0k

Countries citing papers authored by Xue Dong

Since Specialization
Citations

This map shows the geographic impact of Xue Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Dong more than expected).

Fields of papers citing papers by Xue Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Dong. The network helps show where Xue Dong may publish in the future.

Co-authorship network of co-authors of Xue Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Dong. A scholar is included among the top collaborators of Xue Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Dong. Xue Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Li, Jing, Zan Song, Xue Dong, et al.. (2025). VRK1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma mediated by SNAI1 via phosphorylating CHD1L. Cell Death and Disease. 16(1). 302–302.
4.
Li, Dandan, Huanyu Ma, Xue Dong, et al.. (2024). ATF3 deficiency promotes alveolar macrophage pyroptosis in sepsis-induced acute lung injury. Molecular Immunology. 176. 84–95. 1 indexed citations
5.
6.
7.
Chen, Jincheng, Wei Wu, Jian Yi, et al.. (2024). T-stage diagnosis of lung cancer based on deep learning in CT images. 10(4).
8.
Li, Dandan, et al.. (2023). Activating transcription factor 3: A potential therapeutic target for inflammatory pulmonary diseases. Immunity Inflammation and Disease. 11(9). e1028–e1028. 7 indexed citations
9.
10.
Yu, Liming, Xue Dong, Yinli Xu, et al.. (2022). Icariin attenuates excessive alcohol consumption-induced susceptibility to atrial fibrillation through SIRT3 signaling. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(10). 166483–166483. 23 indexed citations
11.
Du, Mei, Xue Dong, Xiaohong Wang, et al.. (2021). The Role of Intravitreal Anti-VEGF Agents in Rabbit Eye Model of Open-Globe Injury. Journal of Ophthalmology. 2021. 1–11. 2 indexed citations
12.
Dong, Xue, et al.. (2021). Pralsetinib for the treatment of non-small cell lung cancer. Drugs of today. 57(9). 559–559. 1 indexed citations
13.
Yu, Liming, Xue Dong, Yinli Xu, et al.. (2021). Activation of PKG-CREB-KLF15 by melatonin attenuates Angiotensin II-induced vulnerability to atrial fibrillation via enhancing branched-chain amino acids catabolism. Free Radical Biology and Medicine. 178. 202–214. 25 indexed citations
14.
Li, Danyang, Xue Dong, Xiaowen Zhang, et al.. (2021). LncDACH1 promotes mitochondrial oxidative stress of cardiomyocytes by interacting with sirtuin3 and aggravates diabetic cardiomyopathy. Science China Life Sciences. 65(6). 1198–1212. 46 indexed citations
15.
Shi, Qianqian, Renfang Xu, Lu Hao, et al.. (2020). Correction: GATA3 suppresses human fibroblasts-induced metastasis of clear cell renal cell carcinoma via an anti-IL6/STAT3 mechanism. Cancer Gene Therapy. 27(12). 979–982. 5 indexed citations
16.
Wan, Yue, Min Qiang, Xue Dong, et al.. (2019). A cell–cell interaction format for selection of high-affinity antibodies to membrane proteins. Proceedings of the National Academy of Sciences. 116(30). 14971–14978. 32 indexed citations
17.
Yu, Liming, Xue Dong, Xiaodong Xue, et al.. (2019). Protection of the myocardium against ischemia/reperfusion injury by punicalagin through an SIRT1-NRF-2-HO-1-dependent mechanism. Chemico-Biological Interactions. 306. 152–162. 47 indexed citations
18.
Zhao, Jing, et al.. (2018). Expression of plasma miR-106a in epithelial ovarian cancer and its diagnostic and prognostic significance. European Journal of Gynaecological Oncology. 39(5). 769–772. 3 indexed citations
19.
Dong, Xue, Zhongli Yang, & Jun Zhang. (2018). Decreased miR-452 expression in human cervical cancer and its prognostic significance. European Journal of Gynaecological Oncology. 39(1). 27–31. 2 indexed citations
20.
Tamura, Ryuji, Hideo Takahashi, Xue Dong, et al.. (2004). Enhanced Effects of Combined Bu-Zhong-Yi-Qi-Tang (TJ-41) and Interleukin-18 on the Production of Tumour Necrosis Factor-α and Interferon-γ in Human Peripheral Blood Mononuclear Cells. Journal of International Medical Research. 32(1). 25–32. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanli Cheng Breakdown of academic impact, for papers by Yinli Xu Breakdown of academic impact, for papers by Manling Liu Breakdown of academic impact, for papers by Silvia Palmerio Breakdown of academic impact, for papers by Xiaopei Cui Breakdown of academic impact, for papers by Lele Ji Breakdown of academic impact, for papers by Xiangning Cui Breakdown of academic impact, for papers by Manyu Luo
Rankless by CCL
2026